Protagenic Therapeutics
OTC: PTIX
$0.77
as on
Protagenic Therapeutics Stock Performance
as on October 3, 2026 at 3:23 am IST
Day's Low
Day's High
$0.77$0.78
0.50%
Downside
0.79%
Upside
52 Week's Low
52 Week's High
$0.13$3.7783.43%
Downside
387.14%
Upside
Protagenic Therapeutics share price movements today
- Previous Close
- $0.78
- Open
- $0.78
- Volume
- 119.9K
- Market Cap
- $1.4M
- Day's Low - High
- $0.77 - $0.78
- 52 Week Low - High
- $0.13 - $3.77
Protagenic Therapeutics Historical Returns
- 1 Month Return
- -22.61 %
- 3 Month Return
- + 236.48 %
- 1 Year Return
- -76.48 %
- 3 Year Return
- -96.79 %
- 5 Year Return
- -99.26 %
Protagenic Therapeutics Stock Fundamentals & Key Indicators
Check Protagenic Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4M
EPS (TTM)
2.95
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0.26
Industry PE ratio
-2.27
PEG Ratio
0.00
EBITDA
-4.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-794.18%
Protagenic Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Protagenic Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $1.4M | -99.26% | 0.26 | 0.00% | 0.00% | |
| StrongBuy | $23.7B | 305.84% | -26.68 | 83.27% | 0.00% | |
| StrongBuy | $30.9B | 14.03% | 37.86 | 79.72% | 0.00% | |
| StrongBuy | $132.5B | 180.98% | 30.19 | 86.04% | 0.00% | |
| Buy | $78.1B | 28.80% | 17.67 | 84.86% | 0.50% |
Stock Returns calculator for Protagenic Therapeutics Stock including INR - Dollar returns
The Protagenic Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Protagenic Therapeutics investment value today
Current value as on today
₹25,532
Returns
Returns from Protagenic Therapeutics Stock
Dollar Impact
₹2,009 (+2.01%)
Analyst Recommendation on Protagenic Therapeutics Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Protagenic Therapeutics. Average target price of $4
Protagenic Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Protagenic Therapeutics.
What analysts predicted
80.65%UPSIDE
Target Price
$4
Current Price
$0.7739
Analyzed by
7 Analysts
Target
$4.00
Protagenic Therapeutics target price $4, a slight upside of 80.65% compared to current price of $0.7739. According to 7 analysts rating.
Protagenic Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Protagenic Therapeutics Annual Profit & Loss
All numbers in Millions USD
Protagenic Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Protagenic Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Protagenic Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Insmed Incorporated has given 165.0% return, outperforming this stock by 257.9%
- NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 847.0% return, outperforming this stock by 944.6%
NEGATIVE IMPACTPrice Dip
In the last 7 days, PTIX stock has moved down by -56.2%
About Protagenic Therapeutics
| Organisation | Protagenic Therapeutics |
| Headquarters | 149 Fifth Avenue, New York, NY, 10010, US |
| Industry | Biotechnology |
| CEO | Garo H. Armen |
Key Management of Protagenic Therapeutics
Name | Title |
|---|---|
Dr. Robert Benjamin Stein M.D., Ph.D. | Chief Medical Officer |
Dr. Andrew Slee Ph.D. | Chief Development Officer |
Dr. Garo H. Armen Ph.D. | Executive Chairman |
Mr. William Nichols Jr. | President |
FAQs
What is Protagenic Therapeutics share price today?
Protagenic Therapeutics share price today is $0.77 as on at the close of the market. Protagenic Therapeutics share today touched a day high of $0.78 and a low of $0.77.
What is the 52 week high and 52 week low for Protagenic Therapeutics share?
Protagenic Therapeutics share touched a 52 week high of $3.77 on and a 52 week low of $0.13 on . Protagenic Therapeutics stock price today i.e. is closed at $0.77,which is 79.47% down from its 52 week high and 503.67% up from its 52 week low.
What is Protagenic Therapeutics's market capitalisation today?
Protagenic Therapeutics market capitalisation is $0.00T as on .
How to invest in Protagenic Therapeutics Stock (PTIX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Protagenic Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Protagenic Therapeutics Stock (PTIX) from India?
Indian investors can start investing in Protagenic Therapeutics (PTIX) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Protagenic Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Protagenic Therapeutics share’s latest price of $0.77 as on October 2, 2026 at 9:53 pm IST, you will get 12.9216 shares of Protagenic Therapeutics. Learn more about
fractional shares .
What are the returns that Protagenic Therapeutics has given to Indian investors in the last 5 years?
Protagenic Therapeutics stock has given -99.26% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?